200,000+ products from a single source!
sales@angenechem.com
233254-24-5 | Propanamide, N-[4-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]phenyl]-2-(hydroxymethyl)-2-methyl-
CAS No: 233254-24-5 Catalog No: AG002MUQ MDL No:
Product Description
Catalog Number:
AG002MUQ
Chemical Name:
Propanamide, N-[4-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]phenyl]-2-(hydroxymethyl)-2-methyl-
CAS Number:
233254-24-5
Molecular Formula:
C23H27N3O4S
Molecular Weight:
441.5432
IUPAC Name:
N-[4-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]phenyl]-3-hydroxy-2,2-dimethylpropanamide
InChI:
InChI=1S/C23H27N3O4S/c1-23(2,15-27)22(28)24-16-11-13-17(14-12-16)25-31(29,30)21-10-6-7-18-19(21)8-5-9-20(18)26(3)4/h5-14,25,27H,15H2,1-4H3,(H,24,28)
InChI Key:
OSQAKHSYTKBSPB-UHFFFAOYSA-N
SMILES:
OCC(C(=O)Nc1ccc(cc1)NS(=O)(=O)c1cccc2c1cccc2N(C)C)(C)C
UNII:
0YPQ44B589
Properties
Complexity:
711
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
441.172g/mol
Formal Charge:
0
Heavy Atom Count:
31
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
441.546g/mol
Monoisotopic Mass:
441.172g/mol
Rotatable Bond Count:
7
Topological Polar Surface Area:
107A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.7
Literature
| Title | Journal |
|---|---|
| In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. | Antimicrobial agents and chemotherapy 20100301 |
| The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs. | Antiviral research 20050101 |
| Antiviral therapies. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040401 |
| Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus. | Antiviral research 20021001 |
| [Drugs against human cytomegalovirus]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020901 |
| Focus on new drugs in development against human cytomegalovirus. | Drugs 20020101 |
| Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. | The Journal of antimicrobial chemotherapy 20011201 |
| A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. | Journal of virology 20011001 |
| Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir. | Antimicrobial agents and chemotherapy 20011001 |
| Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo. | Antiviral research 20010301 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.